Sampath Anand, EVP of Operations and Clinical Research at Masimo Corp ($MASI), sold about $2.56 million in company shares across three open market transactions in the last year. His most recent sale occurred on January 28, 2026. These sales rank 3,011th among 11,678 individual insiders by total value, below the average of $8.6 million per seller and 6.4 transactions. Anand made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Operations | A | Restricted Stock Units | 6840 | $0.00 | 6,840.0000 | 53,100,000 | 9999.99% | 0.01% |
| Jan. 28, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Ops & Clinical Research | M | Common Stock | 30000 | $37.84 | 59,589.0000 | 53,100,000 | 101.39% | 0.06% |
| Jan. 28, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Ops & Clinical Research | S | Common Stock | 11924 | $136.56 | 47,665.0000 | 53,100,000 | 20.01% | 0.02% |
| Jan. 28, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Ops & Clinical Research | S | Common Stock | 6560 | $137.22 | 41,105.0000 | 53,100,000 | 13.76% | 0.01% |
| Jan. 28, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Ops & Clinical Research | S | Common Stock | 196 | $138.09 | 40,909.0000 | 53,100,000 | 0.48% | 0.00% |
| Jan. 28, 2026 | MASIMO CORP | $MASI | Sampath Anand | EVP, Ops & Clinical Research | M | Non-Qualified Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 53,100,000 | 100.00% | 0.06% |